QCG
EXAS

Quadrant Capital Group’s Exact Sciences EXAS Stock Holding History

Quadrant Capital Group’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-577
Closed -$58.6K – 2748
2025
Q4 		$58.6K Sell
577
-9
-2% -$723 ﹤0.01% 1640
2025
Q3 		$32.1K Buy
+586
New +$29.3K ﹤0.01% 1807
2025
Q2 		– Sell
-654
Closed -$28.3K – 1755
2025
Q1 		$28.3K Sell
654
-265
-29% -$13.4K ﹤0.01% 1924
2024
Q4 		$51.6K Sell
919
-4
-0.4% -$249 ﹤0.01% 1396
2024
Q3 		$62.9K Buy
923
+144
+18% +$8.13K ﹤0.01% 1328
2024
Q2 		$32.9K Sell
779
-227
-23% -$12.5K ﹤0.01% 1622
2024
Q1 		$69.5K Sell
1,006
-224
-18% -$14.2K 0.01% 1193
2023
Q4 		$91K Buy
1,230
+330
+37% +$21.6K 0.01% 1054
2023
Q3 		$61.4K Sell
900
-4
-0.4% -$339 0.01% 1147
2023
Q2 		$84.9K Buy
904
+4
+0.4% +$312 0.01% 963
2023
Q1 		$61K Buy
900
+31
+4% +$1.99K 0.01% 1117
2022
Q4 		$43K Buy
869
+52
+6% +$2.13K ﹤0.01% 1249
2022
Q3 		$27K Buy
817
+85
+12% +$3.5K ﹤0.01% 1383
2022
Q2 		$29K Sell
732
-233
-24% -$12.5K ﹤0.01% 1115
2022
Q1 		$67K Sell
965
-350
-27% -$25.6K 0.01% 822
2021
Q4 		$102K Buy
1,315
+253
+24% +$22.3K 0.01% 654
2021
Q3 		$101K Buy
1,062
+149
+16% +$15.7K 0.01% 618
2021
Q2 		$113K Sell
913
-30
-3% -$3.58K 0.02% 562
2021
Q1 		$124K Buy
943
+48
+5% +$6.57K 0.02% 495
2020
Q4 		$119K Buy
895
+74
+9% +$8.95K 0.02% 442
2020
Q3 		$84K Sell
821
-477
-37% -$41.2K 0.02% 485
2020
Q2 		$113K Buy
1,298
+510
+65% +$40.7K 0.03% 414
2020
Q1 		$46K Sell
788
-68
-8% -$5.52K 0.01% 913
2019
Q4 		$77K Sell
856
-315
-27% -$27.7K 0.01% 1114
2019
Q3 		$103K Buy
1,171
+12
+1% +$1.37K 0.02% 857
2019
Q2 		$136K Hold
1,159
– – 0.02% 719
2019
Q1 		$98K Buy
1,159
+553
+91% +$47.1K 0.02% 810
2018
Q4 		$37K Buy
606
+9
+2% +$618 0.01% 989
2018
Q3 		$47K Hold
597
– – 0.01% 673
2018
Q2 		$35K Hold
597
– – 0.01% 775
2018
Q1 		$24K Hold
597
– – 0.01% 880
2017
Q4 		$31K Hold
597
– – 0.01% 767
2017
Q3 		$28K Hold
597
– – 0.01% 788
2017
Q2 		$21K Hold
597
– – 0.01% 850
2017
Q1 		$14K Hold
597
– – 0.01% 959
2016
Q4 		$7K Hold
597
– – ﹤0.01% 1133
2016
Q3 		$11K Hold
597
– – 0.01% 1018
2016
Q2 		$7K Buy
+597
New +$4.5K ﹤0.01% 1119

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Quadrant Capital Group's EXAS Position: Q1 2026 in Review

Quadrant Capital Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 577 shares — an estimated $58.6K sold.

Quadrant Capital Group first reported a position in EXAS in Q2 2016 and held it in 38 quarters. The position peaked at $136K in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Quadrant Capital Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 577 Exact Sciences shares in Q1 2026, an estimated $58.6K.
  • Quadrant Capital Group first reported a position in Exact Sciences in Q2 2016 and held it in 38 quarters.
  • Quadrant Capital Group's Exact Sciences position peaked at $136K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.